- $12.90bn
- $12.20bn
- $1.79bn
Annual balance sheet for Symbotic, fiscal year end - September 28th, USD millions except per share, conversion factor applied.
2020 September 26th | 2021 September 25th | 2022 September 24th | 2023 September 30th | 2024 September 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 58.3 | 157 | 353 | 546 | 727 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.49 | 63.4 | 105 | 190 | 420 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 212 | 260 | 605 | 992 | 1,356 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.19 | 18.6 | 24.9 | 46.9 | 112 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 225 | 281 | 631 | 1,051 | 1,579 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 147 | 337 | 523 | 1,025 | 1,017 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 409 | 558 | 624 | 1,051 | 1,381 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -184 | -277 | 7.18 | 0.082 | 197 |
| Total Liabilities & Shareholders' Equity | 225 | 281 | 631 | 1,051 | 1,579 |
| Total Common Shares Outstanding |